Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Switch to FNB Business

Product shop

By Turnover

First Business Zero (R0 - R5 million p.a) Gold Business (R0 - R5 million p.a) Platinum Business (R5 million - R60 million p.a) Enterprise Business (R60 million - R150 million+ p.a)

Transact

Business Accounts Credit Cards Cash Solutions Merchant Services eWallet Pro Staffing Solutions ATM Solutions Ways to bank Fleet Services Guarantees

Savings and Investments

Save and Invest 3PIM (3rd Party Investment Manager)

Borrow

FNB Cash Advance Overdraft Loans Debtor Finance Leveraged Finance Private Equity Securities Based Lending Selective Invoice Discounting Asset Based Finance Alternative Energy Solutions Commercial Property Finance Fleet Services

Insure

Insurance

For my employees

Staffing Solutions Employee benefits

Forex + Trade

Foreign Exchange Imports and exports Structured Trade + Commodity Finance Business Global Account (CFC account)

Value Adds + Rewards

Connect my business the dti initiatives Enterprise and supplier development Business Hub eBucks Rewards for Business DocTrail™ CIPC Integration Channel Instant Accounting Solutions Instant Payroll Instant Cashflow Instant Invoicing SLOW 24/7 Business Desk FNB Business Fundaba nav» Marketplace Prepaid products Accounting integrations

Industry Expertise

Philanthropy Chinese Business Islamic Banking Agriculture Public Sector Education Healthcare Franchise Motor Dealership Tourism

Going Global

Global Commercial Banking

Financial Planning

Overview

Bank Better

KYC / FICA Debit order + recipient switching Electronic Alerts

Corporates + Public Sector

Corporate Public Sector

All savings + investment accounts


Cash deposits

Notice deposits Immediate access Access to a portion Fixed deposits

Share investing

Shares

Tax-free investing

Tax-free accounts

Funds/unit trusts

Ashburton specialised products

Invest abroad

Offshore products

I want to save for

Personal goals Child's education Emergencies Tax-free

Compare similar

Compare

Additional options

Show me all Help me chosse Find an advisor

Financial planning

Overview

Filter by

Subcategory

Types

Time period

Equity Insights

Equity Insights

PepsiCo - (Soda)stream of dividends?

PepsiCo runs a complementary beverage and convenience foods portfolio that includes Lay's, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, and SodaStream. It oversees the manufacturing, distribution, and marketing of its products that are sold in over 200 countries globally.

17 June 2025

Equity Insights

Greencoat Renewables - Sustainable energy for sustainable cashflows

09 June 2025

Equity Insights

Capitec - Banking on the future

27 May 2025

Equity Insights

Corporate Action: Anglo American (AGL) - Demerger of Valterra Platinum and Share Consolidation

20 May 2025

Equity Insights

SPM Best Ideas - Offshore - May 2025

A look at our best offshore investment ideas from our FNB investment research team.

15 May 2025

Equity Insights

SPM Best Ideas - Midcaps - May 2025

15 May 2025

Equity Insights

SPM Best Ideas - Local Large-Cap - May 2025

15 May 2025

Equity Insights

4Sight Holdings - 4Seeing excellent growth

13 May 2025

Equity Insights

Ferrari NV- RAC(E)ing ahead of the competition

12 May 2025

Equity Insights

BlackRock - (Black)Rock solid

BlackRock began in 1988 as a fixed income institutional asset manager with expertise in enterprise risk management. The company began operating with eight people in a single room. BlackRock has since meaningfully diversified its product set and is now the largest asset manager in the world with $11.6 trillion in assets under management as of the end of 4Q24. The company is headquartered in New York City and has a presence in 42 countries with clients in over 100 countries. BlackRock has grown both organically and acquisitively and has an impressive record of bedding down acquisitions of varying size. The company is led by Co-founder, Chairman and CEO, Larry Fink.

24 March 2025

Equity Insights

ASML

19 March 2025

Equity Insights

FNB to list sixteen new single-stock ETNs this month

18 March 2025

Equity Insights

The Walt Disney Company - Magical IP Monetisation

13 March 2025

Equity Insights

Airbnb - Checking in: The ultimate experience for investors?

24 February 2025

Equity Insights

LVMH Moet Hennessy Louis Vuitton - Popping the cork on luxury

In 1987 Louis Vuitton and Moet Hennessy merged, creating the LVMH Group. As a family-run group, LVMH strives to ensure the long-term development of each of its Houses in keeping with their identity, heritage, and expertise. LVMH is home to 75 distinguished Houses rooted in six different sectors across 80 countries. The company produces and sells Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewellery, and Selective Retailing.

13 February 2025

Equity Insights

Stock Picks 2025

24 January 2025

Equity Insights

Broadcom Inc. - Scaling through diversification

23 January 2025

Equity Insights

FNB ETN Quarterly Update - 4Q24

20 January 2025

Equity Insights

Novo Nordisk: The Ozempification of success

20 January 2025

Equity Insights

L'Oreal - Beauty is in the eye of the (share)holder

In 1909, Eugene Schueller founded the company that was to become the L'Oreal Group after developing one of the first safe and effective hair dyes that he formulated, manufactured, and sold to Parisian hairdressers. The business grew rapidly from then, both organically and acquisitively, with organic growth centred upon science and innovation. In the 1930's the company began expanding internationally and in the 1950's the company ventured into skincare with an arrangement with Vichy which it later acquired in 1980. Notably, L'Oreal also acquired Lancome in 1954 and Garnier in 1965. In 1973, the company entered the healthcare market when it assumed controlling interest in Synthelabo, a company specialising in cardiovascular medications which, after combining with over-the-counter specialist Metabio-Joullie in 1980, became the third largest pharmaceutical company in France.

16 January 2025

Filter by

Subcategory

Types

Time period

Disclaimer

This Publication note is issued by FNB for the information of clients only and should not be produced in whole or part without prior permission. Although FNB is an Authorised Financial Services Provider, any opinions and/or analysis contained in this Publication are for informational purposes only and should not be considered advice, including but not limited to financial, legal or tax advice, or a recommendation to invest in any security or to adopt any investment strategy. The information contained herein has been obtained from sources/persons which we believe to be reliable. Still, it is not guaranteed for correctness, completeness or otherwise. We do not assume liability for loss arising from errors in the information or that may be suffered from using or relying on the information contained herein, irrespective of whether there has been any negligence by us, our affiliates or any other employees of ours, and whether such losses are direct or consequential. As market and economic conditions are subject to rapid change, any comments, opinions and analyses are rendered as of the date of publishing and may change without notice. Such changes may have a material impact on the outcome of any investment. Securities involve a degree of risk and are volatile instruments. Past performance is not indicative of future performance. Securities or financial instruments mentioned in the Publication note may not be suitable for all investors, and FNB bears no responsibility whatsoever arising from or as a consequence thereof. The material is not intended as a complete analysis of every material fact regarding any share, instrument, sector, region, market, country, investment or strategy. The recipient of this Publication must make their own investment decision and is advised to contact their relationship manager for a personal financial analysis before making any investment decisions. Copyright 2023.

How would you like to log in?